Bubs Australia Ltd (ASX:BUB) was founded in 2006 by Kristy Carr and was listed on the ASX in January 2017. Its infant formula is based on goat milk and it also sells organic baby food. Bubs recently acquired NuLac Foods, Australia’s largest producer of goat milk products, it also guarantees exclusive supply of local goat milk from Australia’s largest herd of milking goats.
Drew Meredith from Wattle Partners and Owen Raszkiewicz from Rask Australia share their best and worst from Reporting Season, including QBE Insurance (ASX:QBE), PointsBet Ltd (ASX:PBH) and more.
Bubs Australia Ltd (ASX:BUB) has announced a capital raising for $38 million, should investors buy shares?
On the last day of ASX reporting season, Bubs Australia Ltd (ASX: BUB) shares entered a special 2+2 trading halt. Meaning, Bubs shares cannot be traded for four trading days, or until the company releases an update to the market.
The Bubs Australia Ltd (ASX:BUB) share price is up around 5% after the company announced a manufacturing agreement.
There are some ASX shares that I’d buy for my portfolio in August 2020. Investors need to tread carefully at the moment due to COVID-19.
The Bubs (ASX:BUB) share price is down 5% after announcing its FY20 fourth quarter, a global brand ambassador and a new range of products.
Let’s take a look three ASX infant formula shares at different stages of their growth journies: a2 Milk (ASX:A2M), Bubs Australia (ASX:BUB) and Nuchev (ASX:NUC).
Bubs (ASX:BUB) is an ASX small cap that growth-focused investors might like to keep an eye on.
Is the ASX 200 (ASX:XJO) in a bull market or a bear market? Is it time to buy ASX shares?
